H.B.4407. Education; curriculum; health curriculum; instruction on prescription opioid drug abuse prevention; require. Amends 1976 PA 451 (MCL 380.1 - 380.1852) by adding sec. 1503.

Michigan House of Representatives
Last action a year ago
Polls (closed):
Yay (0)    Nay (0)

Sponsors

66, Joseph Bellino (R)

Summary

                    House Bill 4407 would add a section to the Revised School Code (proposed MCL 380.1503) that would require the board of a school district or board of directors of a public school academy (PSA, or charter school) to include a program on prescription opioid drug abuse in its required health education curriculum.[2] 

No later than July 1, 2018, the MDE must develop or adopt a model program of instruction on prescription opioid drug abuse based on the recommendations developed by the Commission, described above. This model program must include, at least, instruction on the prescription drug epidemic and the connection between prescription opioid drug abuse and addiction to other drugs.
                
Advertisment
why ads?


                    This analysis was prepared by nonpartisan House Fiscal Agency staff for use by House members in their deliberations, and does not constitute an official statement of legislative intent.
                

In an effort to be an unbiased source of information, all text in this summary comes directly from government resources.

Actions

  • assigned PA 255'17 with immediate effect

    Wed, Dec 27th 2017
  • presented to the Governor 12/18/2017 @ 11:20 AM

    Wed, Dec 27th 2017
  • filed with Secretary of State 12/27/2017 @ 2:34 PM

    Wed, Dec 27th 2017
  • approved by the Governor 12/27/2017 @ 12:22 PM

    Wed, Dec 27th 2017
  • REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • bill ordered enrolled

    Tue, Dec 12th 2017
  • full title agreed to

    Tue, Dec 12th 2017
  • Roll Call # 507 Yeas 105 Nays 5

    Tue, Dec 12th 2017
  • Senate substitute S-1 concurred in

    Tue, Dec 12th 2017
  • rule suspended

    Tue, Dec 12th 2017
  • laid over one day under the rules

    Tue, Dec 12th 2017
  • returned from Senate with substitute S-1 with immediate effect and full title

    Tue, Dec 12th 2017
  • INSERTED FULL TITLE

    Tue, Dec 12th 2017
  • PASSED; GIVEN IMMEDIATE EFFECT ROLL CALL # 533 YEAS 37 NAYS 1 EXCUSED 0 NOT VOTING 0

    Tue, Dec 12th 2017
  • REPORTED FAVORABLY WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • COMMITTEE RECOMMENDED IMMEDIATE EFFECT

    Tue, Dec 12th 2017
  • REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • PLACED ON IMMEDIATE PASSAGE

    Tue, Dec 12th 2017
  • SUBSTITUTE S-1 CONCURRED IN

    Tue, Dec 12th 2017
  • PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • RULES SUSPENDED

    Tue, Dec 12th 2017
  • REFERRED TO COMMITTEE ON HEALTH POLICY

    Tue, Jun 13th 2017
  • read a third time

    Mon, Jun 12th 2017
  • transmitted

    Mon, Jun 12th 2017
  • title amended

    Mon, Jun 12th 2017
  • passed; given immediate effect Roll Call # 204 Yeas 102 Nays 5

    Mon, Jun 12th 2017
  • placed on third reading

    Tue, Jun 6th 2017
  • substitute H-1 adopted

    Tue, Jun 6th 2017
  • read a second time

    Tue, Jun 6th 2017
  • referred to second reading

    Tue, May 23rd 2017
  • reported with recommendation with substitute H-1

    Tue, May 23rd 2017
  • bill electronically reproduced 03/23/2017

    Mon, Mar 27th 2017
  • read a first time

    Wed, Mar 22nd 2017
  • referred to Committee on Health Policy

    Wed, Mar 22nd 2017
  • introduced by Representative Beth Griffin

    Wed, Mar 22nd 2017